JXHL1600151 | ASP015K片 | peficitinib hydrobromide | Tablet | Chemical Drugs(1) | Import Drug Application | 2016-12-30 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2017-10-19 | view |
JYHB2000452 | ASP015K片 | peficitinib hydrobromide | Tablet | Chemical Drugs | Supplementary Application | 2020-04-24 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2020-06-10 | view |
JXHL1500239 | ASP2215片 | gilteritinib fumarate | Tablet | Chemical Drugs | Import Drug Application | 2015-09-14 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2016-12-12 | view |
JXSL2000081 | ASP7517注射液 | ASP7517 | Injection | Biological Products | Import Drug Application | 2020-06-20 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2020-06-19 | view |
JXHL1600046 | ASP8273胶囊 | naquotinib | Capsule | Chemical Drugs | Import Drug Application | 2016-04-07 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2017-05-24 | view |
JXSL1900138 | ASP9801注射液 | ASP9801 | Injection | Biological Products | Import Drug Application | 2019-12-10 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2019-12-06 | view |
JXHL1800151 | Enzalutamide软胶囊 | enzalutamide | Soft capsules | Chemical Drugs(2.4) | Import Drug Application | 2018-10-31 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2018-10-30 | view |
JXHL1900271 | Fezolinetant片 | fezolinetant | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-10-23 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2019-10-22 | view |
JXHL1900270 | Fezolinetant片 | fezolinetant | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-10-23 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2019-10-22 | view |
JXHL1900269 | Fezolinetant片 | fezolinetant | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-10-23 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2019-10-22 | view |
JXHL1900272 | Fezolinetant片 | fezolinetant | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-10-23 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | In Review | 2019-10-22 | view |
JXHL1600028 | MDV3100片 | enzalutamide | Tablet | Chemical Drugs | Import Drug Application | 2016-02-29 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2016-09-07 | view |
JXHL1600029 | MDV3100片 | enzalutamide | Tablet | Chemical Drugs | Import Drug Application | 2016-02-29 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2016-09-07 | view |
JXHL1600099 | MDV3100胶囊 | enzalutamide | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2016-09-05 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2017-03-27 | view |
JXHL1300312 | MDV3100胶囊 | enzalutamide | Capsule | Chemical Drugs | Import Drug Application | 2013-08-19 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2014-07-24 | view |
JYHZ1300398 | 丙酸交沙霉素 | josamycin propionate | Active ingredient | Chemical Drugs | License Renew | 2013-09-06 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2016-02-04 | view |
CYHB1402131 | 交沙霉素片 | josamycin | Tablet | Chemical Drugs | Supplementary Application | 2014-06-30 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2015-02-25 | view |
CYHB1906362 | 交沙霉素片 | josamycin | Tablet | Chemical Drugs | Supplementary Application | 2019-11-19 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2020-04-10 | view |
CYHB1801819 | 交沙霉素片 | josamycin | Tablet | Chemical Drugs | Supplementary Application | 2018-04-08 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2019-03-04 | view |
JYHB1400659 | 他克莫司注射液 | tacrolimus | Injection | Chemical Drugs | Supplementary Application | 2014-05-29 | 安斯泰来制药(中国)有限公司 | Astellas Pharmaceutical (China) Co Ltd | Certificate Issued | 2015-05-05 | view |